一个六岁的孩子对tranexamic酸输液的过敏反应:一个病例报告
Nazanin Zibanejad1,2, Nikta Nouri3, Sharareh Babaie4,5
1Department of Pediatric Intensive Care Unit, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.
International journal of emergency medicine
|September 30, 2024
概括
过敏反应,一种严重的过敏反应,可能发生在儿童接受过胺酸 (TXA) 后,这是用来控制出血的常见药物. 及时识别和治疗对于积极的结果至关重要.
科学领域:
- 麻醉学 麻醉学
- 儿科过敏 儿科过敏
- 药物监督 药物监督 药物监督
背景情况:
- 特兰胺酸 (TXA) 广泛用于儿童和成人手术患者的出血控制.
- 对TXA的过敏反应越来越多地在成年人中报告,但在儿童中记录较少.
- 这一案例突出了儿科患者罕见的不良事件.
研究的目的:
- 报告儿童在三胺酸后出现过敏反应的情况.
- 强调需要对TXA诱导的儿童群体的过敏反应保持警.
- 强调对过敏反应及时诊断和管理的重要性.
主要方法:
- 一名6岁的女性在静脉注射TXA后出现过敏反应,用于裂口唇和 palatal修复.
- 临床表现包括心血管,呼吸系统和皮肤症状.
- 诊断通过阳性皮肤内皮肤试验得到证实.
主要成果:
- 患者的症状在用上腺素,皮质类固醇和抗胰岛素治疗后得到缓解.
- 皮内检测证实了特兰胺酸是过敏反应的原因.
- 这个病例增加了TXA诱导的过敏反应的有限儿科报告.
结论:
- 过敏反应是儿科患者对特兰胺酸的一种潜在不良反应.
- 早期发现和适当的管理对于成功治疗至关重要.
- 临床医生应考虑TXA诱导的过敏反应在小儿科患者呈现过敏症状后的管理.
相关概念视频
Allergic Reactions
Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


